
Medsir allies with Goldman Sachs-owned Oncoclinics
Together with the consultancy Athenea Healthcare Group, we have advised MEDSIR in its strategic alliance with Oncoclínicas, backed by its controlling shareholder Goldman Sachs, enters in MEDSIR's shareholding with 49% to reinforce its international expansion.
MEDSIR is an international independent oncology research company based in Barcelona.
Oncoclinicas is a leading Brazilian group specialised in the treatment of oncology patients in Brazil and Latin America.


